Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |